As specialty drug costs, GLP-1 spending and fiduciary scrutiny increase, many employers are asking whether their pharmacy benefit services can be reconfigured to reduce costs without creating new administrative and clinical risks.1
One strategy getting increased attention is to distribute pharmacy benefit services among multiple vendors.2